JP7890301B2 - 治療用放射線標識コンジュゲート及び治療におけるそれらの使用 - Google Patents
治療用放射線標識コンジュゲート及び治療におけるそれらの使用Info
- Publication number
- JP7890301B2 JP7890301B2 JP2023547721A JP2023547721A JP7890301B2 JP 7890301 B2 JP7890301 B2 JP 7890301B2 JP 2023547721 A JP2023547721 A JP 2023547721A JP 2023547721 A JP2023547721 A JP 2023547721A JP 7890301 B2 JP7890301 B2 JP 7890301B2
- Authority
- JP
- Japan
- Prior art keywords
- compound
- gsao
- nodaga
- therapeutic
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
- C07B59/004—Acyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0402—Organic compounds carboxylic acid carriers, fatty acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N5/1001—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D255/00—Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D249/00 - C07D253/00
- C07D255/02—Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D249/00 - C07D253/00 not condensed with other rings
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Optics & Photonics (AREA)
- Epidemiology (AREA)
- Physics & Mathematics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Pathology (AREA)
- Radiology & Medical Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2020903727 | 2020-10-14 | ||
| AU2020903727A AU2020903727A0 (en) | 2020-10-14 | Conjugates and their use in therapy | |
| PCT/AU2021/051203 WO2022077068A1 (en) | 2020-10-14 | 2021-10-14 | Therapeutic radiolabelled conjugates and their use in therapy |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023547954A JP2023547954A (ja) | 2023-11-14 |
| JP2023547954A5 JP2023547954A5 (cg-RX-API-DMAC7.html) | 2024-10-25 |
| JP7890301B2 true JP7890301B2 (ja) | 2026-07-14 |
Family
ID=81207378
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023547721A Active JP7890301B2 (ja) | 2020-10-14 | 2021-10-14 | 治療用放射線標識コンジュゲート及び治療におけるそれらの使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230398240A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4228710A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7890301B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230130610A (cg-RX-API-DMAC7.html) |
| CN (1) | CN116472068A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021359638A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3195410A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL302033A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2023004327A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022077068A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20220152229A1 (en) | 2019-04-12 | 2022-05-19 | Centenary Institute Of Cancer Medicine And Cell Biology | Conjugates and their use as imaging agents |
| US20250269072A1 (en) * | 2021-10-14 | 2025-08-28 | Centenary Institute Of Cancer Medicine And Cell Biology | Processes for preparing radiolabelled conjugates |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016153054A1 (ja) | 2015-03-25 | 2016-09-29 | 富士フイルム株式会社 | 新規な含窒素化合物またはその塩の製造方法およびそれらの製造中間体 |
| JP7692839B2 (ja) | 2019-04-12 | 2025-06-16 | センテナリ インスティチュート オブ キャンサー メディシン アンド セル バイオロジー | コンジュゲート及びそのイメージング剤としての使用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100418585C (zh) * | 2003-07-24 | 2008-09-17 | 伯拉考成像股份公司 | 稳定的放射性药物组合物及制备方法 |
| WO2016088116A1 (en) * | 2014-12-05 | 2016-06-09 | University Health Network | Use of antioxidants as radio-protective agents |
| US20160367620A1 (en) * | 2015-06-19 | 2016-12-22 | Harry B. Demopoulos | Glutathione |
-
2021
- 2021-10-14 CA CA3195410A patent/CA3195410A1/en active Pending
- 2021-10-14 KR KR1020237015744A patent/KR20230130610A/ko active Pending
- 2021-10-14 CN CN202180075143.7A patent/CN116472068A/zh active Pending
- 2021-10-14 JP JP2023547721A patent/JP7890301B2/ja active Active
- 2021-10-14 WO PCT/AU2021/051203 patent/WO2022077068A1/en not_active Ceased
- 2021-10-14 IL IL302033A patent/IL302033A/en unknown
- 2021-10-14 AU AU2021359638A patent/AU2021359638A1/en active Pending
- 2021-10-14 EP EP21878793.5A patent/EP4228710A4/en active Pending
- 2021-10-14 MX MX2023004327A patent/MX2023004327A/es unknown
-
2023
- 2023-04-12 US US18/299,304 patent/US20230398240A1/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016153054A1 (ja) | 2015-03-25 | 2016-09-29 | 富士フイルム株式会社 | 新規な含窒素化合物またはその塩の製造方法およびそれらの製造中間体 |
| JP7692839B2 (ja) | 2019-04-12 | 2025-06-16 | センテナリ インスティチュート オブ キャンサー メディシン アンド セル バイオロジー | コンジュゲート及びそのイメージング剤としての使用 |
Non-Patent Citations (2)
| Title |
|---|
| Bogdan Mitran et al.,Trastuzumab cotreatment improves survival of mice with PC-3 prostate cancer xenografts treated with the GRPR antagonist 177Lu-DOTAGA-PEG2-RM26,International Journal of Cancer,145,2019年,3347-3358 |
| Ivan Ho Shon, et al.,Preparation of a Dithiol-Reactive Probe for PET Imaging of Cell Deat,Hogg, P. (eds) Functional Disulphide Bonds. Methods in Molecular Biology,vol. 1967,2019年,295-304 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN116472068A (zh) | 2023-07-21 |
| IL302033A (en) | 2023-06-01 |
| KR20230130610A (ko) | 2023-09-12 |
| US20230398240A1 (en) | 2023-12-14 |
| MX2023004327A (es) | 2023-08-30 |
| CA3195410A1 (en) | 2022-04-21 |
| EP4228710A4 (en) | 2025-04-09 |
| EP4228710A1 (en) | 2023-08-23 |
| WO2022077068A1 (en) | 2022-04-21 |
| JP2023547954A (ja) | 2023-11-14 |
| AU2021359638A1 (en) | 2023-06-01 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20231026 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20241015 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20241015 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20250821 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20250826 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20251126 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20260203 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20260421 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20260602 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20260702 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7890301 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |